A note from the NET Research Foundation
on the passing of Aretha Franklin, Queen of Soul
August 16, 2018
We are saddened to hear of the passing of Aretha Franklin, the Queen of Soul, who died of a pancreatic neuroendocrine tumor (pNET) this morning. She was a legend in the music industry and it is difficult to find the appropriate words to express our sadness of this loss. “We understand the challenge and the pain that Ms. Franklin and her family endured as a result of her diagnosis” says Elyse Gellerman, CEO of the NET Research Foundation. “These challenges drive all of us at the NET Research Foundation to fund research to find treatments and cures on behalf of the approximately 170,000 people in the US with neuroendocrine tumors.”
Since 2005, the NET Research Foundation has invested more than $20 million dollars in neuroendocrine tumor research. Neuroendocrine tumors are rare and misunderstood. It is an uncommon cancer that is underfunded and under-resourced.
The NET Research Foundation is the leading private funder of NET cancer research and a nonprofit 501(c)(3) organization. The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for neuroendocrine cancer. NETRF awards large-scale, multi-year research grants to leading scientists at renowned research institutions around the world.
Support NETRF to Foster Innovation and Fuel Discovery
This year our progress signals both the hope and promise of our efforts for you, your family and the patients we serve: together we are getting closer to improved treatments and ultimately cures. As we continue on in the fight against NETs, we are counting on your support for our work.
Patient Resources
Thank you for your Generous Donation!
Your support enables the NET Research Foundation to make rapid progress toward discovering cures for carcinoid, pancreatic, and related neuroendocrine cancers. Tribute gifts can be made in honor or memory of a loved one.
NETRF Recognized as Top-Tier Charity
NETRF’s strong financial position, transparency, and accountability again earned it a 4-star rating by Charity Navigator, a national evaluator of nonprofits. The 4-star rating indicates the utmost in fiscal responsibility, ethical practices, and governance.
News & Updates
Immunotherapy Update: What We’ve Learned
September 11, 2018Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear if or how immunotherapy can be used in NETs. The Neuroendocrine
Let’s Walk for World NET Cancer Day
September 10, 2018Washington, D.C. group to host a local and virtual event eGlobalTech, an IT solutions, cybersecurity, and management-consulting firm based in Arlington, VA, plans a full day of fundraising activities with a 2-mile Family Fun Walk on
Small community experiences big impact from NETs
September 10, 2018In between Sebago Lake and Casco Bay, there’s a Maine community where many people know about NET cancer and can even name someone who has died from it. The abutting towns of North Yarmouth and Cumberland
